Jubilant Life Sciences Ltd announces financial results for the quarter
The Board of Jubilant Life Sciences Limited, an integrated pharmaceutical and life sciences company met today to approve financial results […]
Say something
Tags: business, Business/Finance, Chairman & Managing Director, China, Co-Chairman & Managing Director, Earnings before interest taxes depreciation and amortization, Economy of India, europe, FDA, Finance, Health/Medical/Pharmaceuticals, Healthcare in India, income, investment, Japan, JUBILANT LIFE SCIENCES LIMITED, Montreal, North America, pharmaceutical, Pharmaceutical industry in India, Quality System, radiopharmaceuticals, Reorganization, Rs, Shyam S Bhartia
Drug reduces breast cancer in high-risk women
A Canadian researcher involved in a study that uncovered a drug capable of significantly reducing the risk of breast cancer in high-risk, postmenopausal women calls the finding a “landmark” discovery.
-
-
Flipkart Health+ App Launched
06-04-2022
